BES meeting 2022 (Final program)

Final program

32th Meeting of the Belgian Endocrine Society
October 21 & 22, 2022

(Mdeon visa: 22/V2/10413/008299)

Friday symposia 21-10-2022

14:00	Registration
14:30-15:45	Symposium 1 (sponsored by Ipsen) Chair: Guy T’Sjoen (UGhent) Part 1: Highlights of ECE Focus on neuroendocrine tumors Wouter de Herder (NL, Erasmus MC, Amsterdam) Focus on acromegaly Albert Beckers (ULiège) Part 2: Innovation for patients with patients Mrs S. Llahana (UK, University College of London) Part 3: Discussion/Q&A
15:45-16:00	Pauze
16:00-17:15	Symposium 2 (sponsored by Lilly) A new chapter on incretin development The “RE-NAISSANCE” of GIP Welcome and introduction André Scheen (chair, Belgium) What we have learned in almost two decades of incretin treatment. 16:05-16:15 André Scheen (chair, Belgium) GIP and GLP-1, the twin-cretin hormones: Similarities and differences. 16:15-16:35 Michael Nauck (Germany) Novel dual incretin receptor agonists: surpassing standards in diabetes care. 16:35-16:55 Christophe De Block (Belgium) Panel discussion and audience key questions on data presented 16:55-17:10 Summary and consolidation André Scheen (chair, Belgium)
17:15–17:50	Coffee
17:50–18:00	Welcome B. Velkeniers (VUB), President
18:00–20:00	Symposium: a message from three young emeriti Chair: P. Petrossians (ULiège) How do they grow so tall ? Albert Beckers (ULiège) A 2022 update in the management of prolactinoma. Dominique Maiter (UCL) Immune checkpoint inhibitors and endocrine side effects. Brigitte Velkeniers (VUB)
20:00	Walking dinner

Saturday meeting 22-10-2022

8:00–8:30	Registration Coffee, visit of the exhibits, poster view
8:30–8:50	General assembly B. Velkeniers (VUB), President
8:50-9:00	Introduction of BSED and EYES Inge Van Boxelaer (BSED) Jonathan Mertens (EYES)
9:00–9:30	Clinical grand-round: hypoparathyroidism Introduced by O. Alexopoulou (UCL) Brigitte Decallone (KUL) & Bernard Corvilain (ULB)
9:30-11:00	Communications by young investigators (sponsored by Pfizer)
9:30–10:30	Part 1: Clinical and translational studies Chair: L. Crenier (ULB) Exercise as a non-pharmacological intervention to protect pancreatic beta cells in patients with type 1 and type 2 diabetes. Alexandra Coomans de Brachène (ULB) A plasma miR-193b-365 signature predicts non-responsiveness to Lactococcus lactis-based antigen-specific immunotherapy in new-onset type 1 diabetes. Grabriele Sassi (KUL) The insulin sensitivity index derived from euglycemic clamps is correlated to liver fat content determined by magnetic resonance spectroscopy in type 1 diabetes . Jonathan Mertens (UA) Mortality-related risk factors of inpatients with diabetes and COVID-19: a multicentric retrospective study in Belgium Thomas Servais (UCL)
10:30–11:00	Part 2: Clinical case reports Chair: M. Bex (KUL) Chromosome 22q11.2 deletion syndrome revealed by severe hypocalcemia and pulseless electric activity: Untangling a conglomerate of potential primary etiologic factors. Eric Balti (VITAZ St. Niklaas) Is this just vitiligo? Nelson is hiding. Maarten De Vis (VUB)
11:00–11:45	Coffee break, visit of the exhibits and poster view
11:45–12:00	Selected Belgian Publication Award (sponsored by Sandoz) Introduced by C. De Block (UA)
	Margaretha Visser et al. The Lancet 2021; 397:2275-2283 Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial. Presenting author: Margaretha Visser (KUL)
12:00–12:30	Belgian Endocrine Society Lecture Award (sponsored by Novo) Introduced by B. Velkeniers (VUB), President
	Determinants and consequences of sex steroid exposure in men. Award winner: Bruno Lapauw (UGhent)
12:30–13:00	Invited lecture Chair: Patrick Petrossians (Uliège)
	Menopauze – 20 years after WHI (Women’s Health Initiative). Axelle Pintiaux (ULiège)
13:00–13:15	Award ceremony of the young investigators
13:15	Lunch

Sponsors

Platinum

Gold

Silver